| Literature DB >> 14693125 |
N Hirano1, R Nomura, T Tawara, K Tohyama.
Abstract
Mice aged 1, 4 or 8 weeks were inoculated with haemagglutinating encephalomyelitis virus (HEV), strain 67N, by the intracerebral (i.c.), intranasal (i.n.), intraperitoneal (i.p.), subcutaneous (s.c.), intravenous (i.v.) or oral route, with different doses. In 1-week-old mice, mortality and mean time to death were mostly the same regardless of the inoculation route, except for the oral route, which appeared to be the least effective. The virus killed 4-week-old mice readily by all routes of inoculation except the oral, and 8-week-old mice by i.c., i.n. or s.c. inoculation. In descending order of efficacy, the routes of HEV infection were: i.c., i.n., s.c., i.p., i.v. and oral. To follow the spread of HEV from peripheral nerves to the central nervous system (CNS), the virus was inoculated subcutaneously into the right hind leg of 4-week-old mice. The virus was first detected in the spinal cord on day 2, and in the brain on day 3. The brain titres became higher than those of the spinal cord, reaching a maximum of 10(7)PFU/0.2 g when the animals were showing CNS signs. Viral antigen was first detected immunohistochemically in the lumbar spinal cord and the dorsal root ganglion ipsilateral to the inoculated leg; it was detected later in the pyramidal cells of the hippocampus and cerebral cortex, and in the Purkinje cells of the cerebellum but not in the ependymal cells, choroid plexus cells or other glial cells. The infected neurons showed no cytopathological changes.Entities:
Mesh:
Substances:
Year: 2004 PMID: 14693125 PMCID: PMC7127506 DOI: 10.1016/s0021-9975(03)00083-5
Source DB: PubMed Journal: J Comp Pathol ISSN: 0021-9975 Impact factor: 1.311
Susceptibility of mice aged 1,4 or 8 weeks to inoculation with the virus by different routes
| Results | ||||
|---|---|---|---|---|
| Route | Dose (PFU) | 1 | 4 | 8 |
| Intracerebral | 105 | ND | 5/4.2(4–5) | 5/4.8(4–6) |
| 104 | 5/3.0(3–4) | 5/4.2(3–4) | 5/5.6(5–6) | |
| 103 | 5/3.6(3–4) | 5/5.3(5–6) | 5/6.6(6–7) | |
| 102 | 5/3.6(3–4) | 5/6.5(5–8) | 4/7(7) | |
| 10 | 5/3.8(3–4) | 3/6.3(5–7) | 1/8(8) | |
| Intranasal | 105 | ND | 5/6.8(6–7) | 5/7.6(7–8) |
| 104 | 5/4.4(3–5) | 5/10.0(6–12) | 5/10.5(8–14) | |
| 103 | 5/5.0(4–6) | 2/10.0(10) | 2/12.5(12–13) | |
| 102 | 5/6.0(5–7)) | 0 | 0 | |
| 10 | 3/6.0(5–7) | 0 | 0 | |
| Intraperitoneal | 106 | ND | 5/4.4(4–5) | 3/6.3(6–7) |
| 105 | ND | 5/5.0(4–7) | 1/10(10) | |
| 104 | 5/2.6(2–3) | 2/7(7) | 0 | |
| 103 | 5/3.3(3–4) | 1/7(7) | 0 | |
| 102 | 5/4.3(3–6) | 0 | 0 | |
| 10 | 4/4.3(4–5) | 0 | 0 | |
| Subcutanous | 106 | ND | 5/5.4(4–6) | 5/6.5(6–7) |
| 105 | ND | 5/8.2(5–11) | 5/7.0(6–8) | |
| 104 | 5/2.6(2–3) | 5/8.4(7–12) | 1/8(8) | |
| 103 | 5/3.2(3–4) | 1/9(9) | 0 | |
| 102 | 5/3.7(3–4) | 0 | 0 | |
| 10 | 1/7(7) | ND | ND | |
| Intravenous | 106 | ND | 5/5.6(5–6) | 0 |
| 105 | ND | 5/5.0(5–7) | 0 | |
| 104 | ND | 2/6.0(5–7) | 0 | |
| 103 | ND | 0 | 0 | |
| Oral | 106 | ND | 0 | 0 |
| 105 | 5/5.0(4–6) | 0 | 0 | |
| 104 | 2/6.5(6–7) | 0 | 0 | |
ND, not done.
Deaths in groups of 5/mean number of days (and range) to death.
Fig. 1HEV 67N growth in the spinal cord and brain of mice, killed in groups of three, after subcutaneous (s.c.) inoculation with 105 PFU in the right hind leg. ○- - -○, Spinal cord; ●- - -●, brain.
Fig. 2a–c(a and b) Antigen-positive neurons in the spinal cord on day 3 after s.c. inoculation. (c) Antigen-positive cells in the dorsal root ganglion ipsilateral to the inoculated leg on day 3. IHC. Bars, 100 μm (a and c); 50 μm (b).
Fig. 3a–f(a and b) Antigen-positive pyramidal cells in the cerebral cortex on day 4. (Arrowheads: pial surface). (c and d) Antigen-positive pyramidal cells in the hippocampus on day 4. (e and f) Antigen positive Purkinje cells of the cerebellum on day 4. (Arrows: pial surface). IHC. Short bar, 100 μm (e). Long bar, 100 μm (f). Figs 3a and c are at the same magnification as 3e. Figs 3b and d are at the same magnification as 3f.